| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022820 |
| Receipt No. | R000026017 |
| Official scientific title of the study | Procedure time for gastric endoscopic submucosal dissection according to location, considering both sides of the mucosal circumferential incision and submucosal dissection ; retrospective study |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2016/06/21 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Procedure time for gastric endoscopic submucosal dissection according to location, considering both sides of the mucosal circumferential incision and submucosal dissection ; retrospective study | |
| Title of the study (Brief title) | Procedure time for gastric endoscopic submucosal dissection according to location, considering both sides of the mucosal circumferential incision and submucosal dissection | |
| Region |
|
|
| Condition | ||
| Condition | gastric neoplasm | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The difficulty and procedure time of gastric endoscopic submucosal dissection (ESD) has only been superficially examined with the stomach divided into three areas, namely, the upper, middle, and lower areas. However, there are two important phases that define the procedure time for ESD, the mucosal circumference incision speed (CIS) and submucosal dissection speed (SDS). Furthermore, depending on the situation, various problems can arise from the specific area, which must be clarified during treatment by operators with various skill levels. Thus, we aimed to clarify all the situations that are considered to be different and make a new classification system for procedure time. |
| Basic objectives2 | Others |
| Basic objectives -Others | Objective fact |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The difference between the mucosal circumference incision speed of every 12 location of the stomach
The difference between the submucosal dissection speed of every 12 location of the stomach |
| Key secondary outcomes | Clinicopathological features of every 12 location of the lesion |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | We examined all cases in the databases of the undifferentiated mixed type gastric cancer indicated for ESD according to the Japanese guidelines from April 1, 2009 to July 31, 2014 | |||
| Key exclusion criteria | The first two cases of operators who recently met the criteria during the observation period were excluded. Finally, to include curative en bloc and R0 resection cases only for the study, piecemeal resection, discontinuation, and non-curative resection cases were also excluded | |||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hironori Konuma |
| Organization | Juntendo Nerima Hospital
|
| Division name | Gastroenterology |
| Address | 3-1-10 Takanodai, Nerima-ku, Tokyo 177-8521, Japan |
| TEL | 090-7200-9888 |
| hkonuma@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Hironori Konuma |
| Organization | Juntendo Nerima Hospital |
| Division name | Gastroenterology |
| Address | 3-1-10 Takanodai, Nerima-ku, Tokyo 177-8521, Japan |
| TEL | 090-7200-9888 |
| Homepage URL | |
| hkonuma@juntendo.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology, Juntendo University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | nothing |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 順天堂大学医学部付属順天堂医院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | The 12 locations were 1) lesions at the esophagogastric junction; 2) fornix; 3) lesser curvature of the gastric body; 4) greater curvature of the gastric body;5) anterior wall of the gastric body; 6) posterior wall of the gastric body; 7) lesion across the angle; 8) lesser curvature of the antrum; 9) greater curvature of the antrum;10) anterior wall of the antrum; 11) posterior wall of the antrum; and 12) lesion across from the pylorus ring. A significant difference was found in circumference incision speed (CIS) and submucosal dissection speed (SDS) for each location (p < 0.01), which demonstrates the validity of this classification system. In several locations, CIS and SDS were not consistent with each other. |
| Other related information | no special instruction |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026017 |